ILMN News and Press, Illumina Inc. From 07/09/24

Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base PR Newswire Accessible, highly scalable single-cell technology expands Illumina's multiomics capabilities SAN DIEGO , July 9, 2024 /PRNews...

2024-07-05 06:55:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips When discussing biotechnology, many focus on medication based on biochemical compounds and their downstream effects. Yet several branches of medical genetics and therapeutics have begun to find...

2024-07-03 07:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The personalized medicine market is experiencing significant growth, driven by advancements in genomic technologies and a shift towards more individualized healthcare . In 2024, the market ...

2024-07-01 12:15:03 ET Stephens analyst issues HOLD recommendation for ILMN on July 1, 2024 10:00AM ET. The previous analyst recommendation was Hold. ILMN was trading at $106.67 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current anal...

2024-06-28 23:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-06-28 14:30:06 ET Summary The 'Undercovered' Dozen highlights twelve ideas from the previous week on stocks with limited coverage. If you're looking for yield, two preferred stock ideas are featured, as well as other high yielding dividend-focused options. A spin-off situ...

2024-06-28 04:35:51 ET Summary Illumina has finally completed the divestiture of GRAIL, ending a disastrous chapter in its history. The Company paid $8bn to acquire the cancer testing business it helped to create, which proved to be a disastrous mistake, triggering three years of ...

2024-06-26 09:02:26 ET Summary GRAIL shares started trading on Nasdaq after a spin-off from Illumina, as the EU's regulatory scrutiny weighed on the prior merger. The company offers the Galleri blood test for early cancer detection, with major sales potential still behind MCED leg...

2024-06-25 07:36:11 ET More on GRAIL,, Illumina, etc. Illumina, Inc. (ILMN) Bernstein Strategic Decisions Conference (Transcript) Illumina, Inc. (ILMN) RBC Capital Markets Global Healthcare (Transcript) Illumina: Expect A Slow Rebound Biggest stock movers tod...

Illumina completes the divestiture of GRAIL PR Newswire GRAIL spin-off complete; GRAIL to begin regular way trading as "GRAL" on June 25 Illumina to issue second quarter 2024 results on August 6 ; leadership to present Strategy Update on August 13 ...